CLINICAL_TRIALS
trial_result
· 2018-03-05
Clinical Trial Update: A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain [Phase 3]
Summary
Pfizer conducted a Phase 3 trial evaluating a fixed-dose combination of ibuprofen 250 mg and acetaminophen 500 mg for post-surgical dental pain, with results po…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2018-03-05